PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.08 and traded as high as $0.09. PURE Bioscience shares last traded at $0.09, with a volume of 47,925 shares.
PURE Bioscience Trading Up 12.5 %
The firm has a market cap of $10.07 million, a PE ratio of -2.25 and a beta of 0.35. The stock’s 50 day moving average price is $0.07 and its 200 day moving average price is $0.08.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last issued its quarterly earnings data on Monday, March 17th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.39 million for the quarter.
PURE Bioscience Company Profile
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Featured Articles
- Five stocks we like better than PURE Bioscience
- Canada Bond Market Holiday: How to Invest and Trade
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Consumer Discretionary Stocks Explained
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- What Are the FAANG Stocks and Are They Good Investments?
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
